宠物补充品硫酸软骨素市场：预测（2024-2029）

2022年宠物补充品市场硫酸软骨素市值为726,786,000美元。

硫酸软骨素是一种天然存在于软骨（关节骨周围的保护组织）中的化合物，广泛用于宠物补充品中，以促进关节健康，尤其是对抗骨关节炎(OA) 的狗和猫。它的成分含有饲主在处理宠物的骨关节疾病时通常依赖日常关节补充品。这些补充品被称为软骨保护剂，也可用于减少身体各部位的发炎，特别是那些接触体液和黏液的部位。例如，由于膀胱内壁发炎而频繁排尿的宠物可能会受益于含有葡萄糖胺和软骨素的製剂。

葡萄糖胺和软骨素等软骨保护剂受到许多饲主的青睐，因为它们具有整体性，可以促进宠物的整体健康，而不是简单地缓解症状。此外，这些补充品的副作用往往较少，使您的宠物减少对处方药的依赖。重要的是，软骨保护补充品通常被认为长期使用是安全的，并且可以陪伴宠物的一生。虽然服用软骨素补充品以应对关节损伤是可取的，但也建议在宠物生命早期开始服用关节补充品作为预防措施。

市场驱动因素

• 宠物拥有量增加

在全球范围内，将宠物融入生活方式改变的趋势日益明显，使它们成为世界各地必不可少的伴侣。 COVID-19 大流行导致宠物拥有量增加，特别是在美国，2016 年至 2020 年间，拥有至少一隻狗的家庭比例从 38% 增加到 45%，养猫的比例也从2022 年从25% 增至29%。中国有 7,400 万个家庭、美国有 8,500 万个家庭、欧盟有 9,200 万个家庭拥有一隻狗。这些数字凸显了宠物世界的重要性及其对硫酸软骨素市场的影响。

• 人们越来越认识到硫酸软骨素的重要性

由于人们越来越认识到硫酸软骨素在促进狗和猫的关节健康方面的潜在益处，因此它在宠物补充品领域越来越受欢迎。由于担心可能的副作用，宠物饲主越来越多地寻求自然的方式来照顾他们的宠物。来自软骨和贝类等天然来源的硫酸软骨素符合这种偏好，并且可能是更安全的选择。宠物看护者越来越意识到骨关节炎 (OA) 对宠物生活品质的负面影响。

市场挑战

• 监理挑战构成障碍

监管挑战是宠物补充品领域的一个障碍。目前，AAFCO 仅监督为「食品类型」的补充品的标籤。儘管有关宠物补充品和食品营养补充的科学资讯不断增加，但市场上大多数这些物质及其相应产品的品管、安全性和有效性仍然有限。目前，缺乏关于宠物补充剂和动物营养品的资料。性别。儘管存在证据差距，动物补充品和营养补充的使用仍在增加。兽医和饲主都必须提倡对这些产品进行更严格的监管，并呼吁製造商与研究人员更密切地合作，这不仅是为了市场，也是为了我们宠物的利益。

依宠物类型，宠物补充品的硫酸软骨素市场分为狗和猫。

宠物补充品的硫酸软骨素市场分为两大类：狗和猫。在美国，6510万个家庭将狗视为家庭不可分割的一部分。根据美国宠物产品协会 (APPA) 的数据，猫的陪伴也很重要，因为有 4,650 万家家庭养猫。 APPA 指出，美国宠物饲主中有很大一部分是千禧世代，这凸显了宠物在这群人生活中日益重要的重要性。

欧洲预计将在宠物补充品中占据硫酸软骨素的显着份额

由于宠物拥有率较高，预计欧洲将在宠物补充品中占据相当大的硫酸软骨素份额。根据 FEDIAF Facts & Datas 报导，欧洲养宠物的盛行表明，欧盟有 9,000 万个家庭接受宠物，占家庭总数的 46%。从这些宠物的细分来看，大约有1.1亿隻猫，大约9000万隻狗，大约5000万隻鸟类，大约3000万隻小型哺乳动物，大约1500万隻狗，大约1000个玻璃容器。百万件，展示了宠物的多样性为欧洲家庭的丰富多彩做出了贡献。

公司产品

• 硫酸软骨素 - Unibridge 的硫酸软骨素在多种应用中发挥重要作用，包括作为补充品添加到宠物食品中。硫酸软骨素是专为宠物配製的，通常用于缓解与骨关节炎相关的不适。它还有助于促进健康的膀胱功能。
• 硫酸软骨素 - 山东海宇生物有限公司生产硫酸软骨素（CS），一种源自动物组织的酸性黏多醣。硫酸软骨素为白色或类白色粉末，无臭，有吸湿性。主要医疗用途是治疗关节疾病、缓解疼痛、支持软骨再生、从根本解决关节问题。
• CSbioactive(R) - CSbioactive(R) 是 Bioiberica 经科学检验的硫酸软骨素，已知可促进关节健康。由于科学研究的积累，CSbioactive(R)已被全球认可并采用为基准成分。该产品专为企业对企业用途而设计，作为宠物补充品的关键成分。

目录

第一章简介

• 市场概况
• 市场定义
• 调查范围
• 市场区隔
• 货币
• 先决条件
• 基准年和预测年时间表

第二章调查方法

• 调查资料
• 调查过程

第三章执行摘要

• 研究亮点

第四章市场动态

• 市场驱动因素
• 市场限制因素
• 波特五力分析
• 产业价值链分析

第五章宠物补充品的硫酸软骨素市场：依纯度级别

• 介绍
• 99%水平
• 其他的

第六章宠物补充品硫酸软骨素市场：依宠物类型

• 介绍
• 狗
• 猫

第七章宠物补充品硫酸软骨素市场：按地区

• 介绍
• 美洲
  • 美国
  • 其他的
• 欧洲、中东/非洲
  • 德国
  • 法国
  • 英国
  • 其他的
• 亚太地区
  • 中国
  • 日本
  • 韩国
  • 其他的

第八章竞争环境及分析

• 主要企业及策略分析
• 合併、收购、协议和合作

第九章 公司简介

• Unibridge
• Shandong Haiyu Biological Co., Ltd
• ZPD A/S
• Shandong Runxin Biotechnology Co., Ltd
• Bioiberica SAU

The chondroitin sulfate for pet supplements market was valued at US$726.786 million in 2022.

Chondroitin sulfate, a natural compound present in cartilage, the protective tissue surrounding bones in joints, is a prevalent ingredient in pet supplements aimed at promoting joint health, particularly for dogs and cats grappling with osteoarthritis (OA). Pet owners often turn to daily joint supplements when addressing bone and joint diseases in their pets. These supplements, known as chondroprotective, also find use in mitigating inflammation in various bodily areas, particularly those exposed to fluids or mucus. For instance, pets with frequent urination due to an irritated bladder lining can benefit from formulations containing glucosamine and chondroitin.

Many pet owners prefer chondroprotective like glucosamine and chondroitin due to their holistic approach, promoting overall pet well-being rather than merely alleviating symptoms. Additionally, these supplements tend to have few side effects and enable pets to rely less on prescription medications. Importantly, chondroprotective supplements are generally considered safe for long-term use, potentially for a pet's lifespan. It is advisable to administer chondroitin supplements in response to joint injuries, initiating joint supplements early in a pet's life is also recommended as a preventive measure.

Market Drivers

• Rise in Pet Ownership

Worldwide, there is a growing trend of integrating pets into changing lifestyles, with pets becoming integral companions across the globe. The COVID-19 pandemic witnessed an upswing in pet adoption, notably in the United States, where the percentage of households with at least one dog increased from 38% to 45% between 2016 and 2020, and cat ownership experienced a steady rise from 25% to 29% in 2022. In China, 74 million households own dogs, the United States has 85 million dog owners, and the European Union boasts 92 million dog owners. These figures underscore the global significance of pets and their impact on the chondroitin sulfate market.

• Growing awareness of the significance of chondroitin sulfate

Chondroitin sulfate is gaining popularity in the pet supplement sector as awareness grows regarding its potential advantages for enhancing joint health in dogs and cats. Faced with concerns about possible side effects, pet owners are increasingly inclined toward natural methods to address their pet's well-being. Chondroitin sulfate, sourced from natural origins such as cartilage and shellfish, aligns with this preference, presenting a potentially safer alternative. Pet caregivers are becoming increasingly cognizant of the adverse impact of osteoarthritis (OA) on their pets' quality of life.

Market Challenges

• Regulatory challenges posing a hurdle

Navigating regulatory challenges poses an obstacle in the realm of pet supplements. At present, AAFCO exclusively oversees the labelling of supplements categorized as "food-type". Despite a growing body of scientific information on veterinary pet supplements and nutraceuticals, there persists a scarcity of quality control, safety, and efficacy data for the majority of these marketed substances and the corresponding products available for purchase. Despite this evidence gap, the utilization of veterinary supplements and nutraceuticals is on the rise. It is imperative for veterinarians and pet owners alike to advocate for enhanced enforcement of regulations governing these products and to call for manufacturers to collaborate more closely with researchers for the betterment of pets as well as the market.

By pet type, chondroitin sulfate for the pet supplements market is divided into dogs and cats

The chondroitin sulfate for the pet supplement market is segmented into two categories, i.e, dogs and cats- In the United States, 65.1 million households consider dogs integral family members. The feline companionship is also cherished, as revealed by the 46.5 million households that own a cat, according to the American Pet Products Association (APPA). Notably, the APPA highlights that a significant portion of pet owners in the U.S. are millennials, underscoring the growing importance of pets in the lives of this demographic.

Europe is anticipated to hold a notable share of the chondroitin sulfate for pet supplements

Europe is projected to account for a notable share of the chondroitin sulfate for pet supplements owing to the people's huge ownership of pets in these regions. As the FEDIAF Facts & Figures states the expanding landscape of pet ownership in Europe, indicates that 90 million households in the European Union have embraced the companionship of a pet, representing 46% of households. The breakdown of this pet population reveals approximately 110 million cats, 90 million dogs, 50 million birds, 30 million small mammals, 15 million aquariums, and 10 million terrariums, showcasing the diverse array of pets that contribute to the rich tapestry of European households.

Company Products

• Chondroitin sulfate - Unibridge's Chondroitin sulfate plays a vital role in diverse applications, including its use in pet food as a supplement. Specifically formulated for pets, Chondroitin sulfate is commonly employed to alleviate discomfort associated with osteoarthritis. Additionally, it contributes to the promotion of healthy bladder functions. Packaged in convenient 25kg drums, this product is well-suited for various needs.
• Chondroitin Sulfate - Shandong Haiyu Biological Co., Ltd. manufactures Chondroitin Sulfate (CS), an acid mucopolysaccharide sourced from animal tissues. Presented as a white or white-like powder without any discernible odor, it displays moisture-absorbing characteristics. Its primary medical application lies in the treatment of joint diseases, offering pain relief and supporting cartilage regeneration to address joint problems at a fundamental level. This versatile product finds various applications, including its incorporation into pet food as a supplementary additive, catering to the specific needs of pet dogs.
• CSbioactive® - CSbioactive® represents Bioiberica's scientifically validated chondroitin sulfate, well-known for its promotion of joint health. Acknowledged and employed worldwide as a benchmark component, CSbioactive® is supported by an extensive body of scientific research. This product is designed for business-to-business applications, serving as a key ingredient for pet supplements.

Market Segmentation

By Purity Level

• 99% Level
• Others

By Pet Type

• Cat
• Dog

By Geography

• North America
• USA
• Others
• Europe, Middle East, And Africa
• UK
• Germany
• France
• Others
• Asia Pacific
• China
• Japan
• South Korea
• Others

TABLE OF CONTENTS

1. INTRODUCTION

• 1.1. Market Overview
• 1.2. Market Definition
• 1.3. Scope of the Study
• 1.4. Market Segmentation
• 1.5. Currency
• 1.6. Assumptions
• 1.7. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY

• 2.1. Research Data
• 2.2. Research Process

3. EXECUTIVE SUMMARY

• 3.1. Research Highlights

4. MARKET DYNAMICS

• 4.1. Market Drivers
• 4.2. Market Restraints
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers
  • 4.3.2. Bargaining Power of Buyers
  • 4.3.3. Threat of New Entrants
  • 4.3.4. Threat of Substitutes
  • 4.3.5. Competitive Rivalry in the Industry
• 4.4. Industry Value Chain Analysis

5. CHONDROITIN SULFATE FOR PET SUPPLEMENTS MARKET BY PURITY LEVEL

• 5.1. Introduction
• 5.2. 99% level
• 5.3. Others

6. CHONDROITIN SULFATE FOR PET SUPPLEMENTS MARKET BY PET TYPE

• 6.1. Introduction
• 6.2. Dogs
• 6.3. Cats

7. CHONDROITIN SULFATE FOR PET SUPPLEMENTS FEED MARKET BY GEOGRAPHY

• 7.1. Introduction
• 7.2. Americas
  • 7.2.1. USA
  • 7.2.2. Others
• 7.3. Europe, Middle East and Africa
  • 7.3.1. Germany
  • 7.3.2. France
  • 7.3.3. UK
  • 7.3.4. Others
• 7.4. Asia Pacific
  • 7.4.1. China
  • 7.4.2. Japan
  • 7.4.3. South Korea
  • 7.4.4. Others

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 8.1. Major Players and Strategy Analysis
• 8.2. Mergers, Acquisitions, Agreements, and Collaborations

9. COMPANY PROFILES

• 9.1. Unibridge
• 9.2. Shandong Haiyu Biological Co., Ltd
• 9.3. ZPD A/S
• 9.4. Shandong Runxin Biotechnology Co., Ltd
• 9.5. Bioiberica S.A.U.

Not an exhaustive list